Director, Employee Relations and HR Operations Partner at Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

(Implicit from role: Expertise in employee relations, HR operations, investigations, compliance, and policy development)
(Implicit: Experience advising managers on performance management, conflict resolution, and corrective actions)
(Implicit: Strong partnership skills with HR functions, Legal, and leadership)
(Implicit: Ability to identify trends, recommend improvements, and drive training/process changes)
(Implicit: Knowledge of federal, state, and local employment laws including EEO, FMLA, ADA, wage and hour)

Responsibilities

Lead the company’s employee relations strategy and practices, ensuring a fair, consistent, and values-based approach to all workplace matters
Conduct, oversee, and document internal investigations in collaboration with Legal and the CHRO
Advise leaders and managers on performance management, corrective action, and workplace conflict resolution
Partner with HR and Legal to ensure policies are up to date, employee-friendly, and compliant with applicable laws
Identify ER trends and proactively recommend training or process improvements to strengthen organizational health and prevent recurrence
Manage and resolve employee concerns, investigations, and corrective actions with discretion and integrity
Coach and develop HR team members and managers on effective employee relations practices and documentation standards
Act as a connective point across the HR functions supporting HR Business Partners, Talent Acquisition, Total Rewards, and HRIS to ensure aligned, consistent delivery of HR programs
Partner with HRBPs to advise on organizational design, workforce planning, and performance-related interventions
Contribute to annual HR processes, including performance reviews, compensation planning, talent calibration, and engagement initiatives
Support cross-functional HR initiatives and special projects that advance HR infrastructure, operational excellence, and employee experience
Serve as a thought partner to the HR leadership team on policy interpretation, communications, and change-management efforts
Lead the development, administration and rollout of HR policies
Ensure compliance with federal, state, and local employment laws (e.g., EEO, FMLA, ADA, wage and hour)
Partner closely with Legal on sensitive employee matters, audits, and risk assessments
Promote a culture of inclusion, accountability

Skills

Employee Relations

HR Operations

HR Policies

Compliance

Performance Management

Talent Management

Onboarding

Training

Coaching

Leadership

Amylyx Pharmaceuticals

Develops treatments for neurodegenerative diseases

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes and enhance the quality of life for individuals suffering from neurodegenerative conditions.

Cambridge, MassachusettsHeadquarters

2013Year Founded

$166.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Relyvrio's Phase III failure raises concerns about ALS treatment efficacy.

Low stock offering price suggests potential financial instability.

New CCO may disrupt commercialization strategies if not aligned with goals.

Differentiation

Amylyx focuses on neurodegenerative diseases like ALS and Alzheimer's.

AMX0035 is a promising drug for ALS and Alzheimer's treatment.

Amylyx engages in community awareness campaigns for neurodegenerative diseases.

Upsides

Positive Phase II results for AMX0035 in ALS boost its potential.

Partnership with Gubra accelerates drug development for neurodegenerative diseases.

Regulatory support for rare diseases aids Amylyx's Wolfram syndrome efforts.

Land your dream remote job 3x faster with AI

Try Jobo Free